3353 — Medical Ikkou Co Balance Sheet
0.000.00%
- ¥10bn
- ¥14bn
- ¥48bn
- 79
- 85
- 34
- 77
Annual balance sheet for Medical Ikkou Co, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.
C2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 7,003 | 7,992 | 6,443 | 7,700 | 6,769 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4,734 | 4,888 | 5,007 | 6,058 | 7,479 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 13,655 | 14,577 | 13,240 | 16,723 | 17,965 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 10,115 | 9,865 | 9,587 | 9,117 | 10,042 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 28,554 | 29,094 | 27,506 | 31,659 | 34,232 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 9,098 | 8,416 | 7,455 | 10,404 | 11,669 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 18,069 | 17,711 | 15,456 | 18,419 | 20,134 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 10,485 | 11,383 | 12,049 | 13,241 | 14,098 |
| Total Liabilities & Shareholders' Equity | 28,554 | 29,094 | 27,506 | 31,659 | 34,232 |
| Total Common Shares Outstanding |